MULTISPECIFIC ANTIBODIES, THEREOF ANALOGUES, COMPOSITIONS AND METHODS Russian patent published in 2016 - IPC C12P21/08 C07K16/46 

Abstract RU 2580038 C2

FIELD: chemistry.

SUBSTANCE: invention relates to field of biotechnology. Claimed is method for synthesis of panel of multispecific antibodies for therapy, diagnostics or research, wherein performed is reaction of first fragment of antibody, which has first monospecificity, obtained from first initial antibody, and possessing free sulfhydryl group, with thio-reactive crosslinker to obtain group antibody fragment-crosslinker, and wherein performed is reaction of group antibody fragment-crosslinker in pair with each of three or more additional fragments of antibodies, which have different monospecificity, different from first antibody fragment, each of which has free sulfhydryl group, to obtain panel of multispecific antibodies. In addition, claimed is method for synthesis of panel of analogues of antibodies for therapy, diagnostics and research, wherein performed is reaction of first antibody fragment, possessing free sulphide group, with thio-reactive crosslinker to obtain group antibody fragment- crosslinker, and wherein performed is reaction of group antibody fragment-crosslinker in pairs with each of three or more additional fragments of antibodies, each of which has free sulfhydryl group, to obtain panel of analogues of antibodies, where each of antibody fragments is obtained from one and the same initial antibody.

EFFECT: invention makes it possible to obtain panels of multispecific antibodies or analogues of antibodies, intended for therapy, diagnostics and research.

35 cl, 14 dwg, 5 tbl, 5 ex

Similar patents RU2580038C2

Title Year Author Number
ANTIBODIES WITH CYSTEINE SUBSTITUITIONS AND THEIR CONJUGATES PRODUCED BY GENE ENGINEERING 2011
  • Bkhakta Sunil
  • Dzhunutula Dzhagatkh R.
RU2626537C2
ANTIBODIES WITH CYSTEINE SUBSTITUTIONS OBTAINED BY GENETIC ENGINEERING AND THEIR CONJUGATES 2011
  • Bhakta, Sunil
  • Junutula, Jagath, R
RU2755066C2
RADIOACTIVE ZIRCONIUM- LABELLED ENGINEERED CYSTEINE ANTIBODIES CONJUGATES 2010
  • Dzhill Kherman
  • Dzhunutula Dzhagatkh R.
  • Loumehn Genri B.
  • Marik Jan
  • Tinianou Dzheff
  • Uill'Jams Sajmon
RU2562862C2
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM 2009
  • Chehn', Ivonne
  • Dennis, Mark
  • Dornan, Dehvid
  • Ehlkins, Kristi
  • Dzhunutula, Dzhagatkh, Reddi
  • Polson, Ehndrju
  • Chzhehn, Bin
RU2553566C2
COMPOSITION CONTAINING ANTIBODY BINDING TO DOMAIN II OF HER2, AND ITS ACIDIC VERSIONS 2009
  • Kharris, Rid, Dzh.
  • Motchnik, Pol, A.
RU2543664C2
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM 2008
  • Chehn' Ivonn
  • Dennis Mark
  • Dornan Dehvid
  • Ehlkins Kristi
  • Dzhunutula Dzhagatkh Reddi
  • Polson Ehndrju
  • Chzhehn Bin
RU2511410C2
ANTIBODIES, CAPABLE OF SPECIFIC CONNECTING WITH HER2 2014
  • Li, Dzong-Seo
  • Kim, Kiu-Tae
  • Li, Joung-Kha
  • Li, Sook-Jeon
  • Khvang, In-Sik
  • Ko, Bong-Kook
RU2628094C2
HUMANIZED ANTI-SIRPα ANTIBODIES 2019
  • Verheijden, Gijsbertus Franciscus Maria
RU2812199C2
ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF 2014
  • Fan Tszyanmin
  • Khuan Chantszyan
  • Tszyan Tszin
  • Yao Syuetszin
  • Li Khunven
  • Syuj Tsyaoyuj
  • Li Chzhuanlin
RU2656161C1
TREATMENT OF CANCER WITH HER2XCD3 BISPECIFIC ANTIBODIES IN COMBINATION WITH ANTI-HER2 MAB 2020
  • Dzhunttila, Timu, T.
  • Luttsker, Styuart
RU2793296C1

RU 2 580 038 C2

Authors

Sheer Dzhastin

Vandlen Richard L.

Dates

2016-04-10Published

2010-12-03Filed